Choice International Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 11:01 am

Competitors of Choice International Ltd

All Competitor Stocks of Choice International Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:31 am

Below is a detailed analysis of the quarterly data for Choice International Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 253.00 Cr.. The value appears strong and on an upward trend. It has increased from 209.00 Cr. (Dec 2024) to 253.00 Cr., marking an increase of 44.00 Cr..
• For Expenses, as of Mar 2025, the value is 157.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 150.00 Cr. (Dec 2024) to 157.00 Cr., marking an increase of 7.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 96.00 Cr.. The value appears strong and on an upward trend. It has increased from 60.00 Cr. (Dec 2024) to 96.00 Cr., marking an increase of 36.00 Cr..
• For OPM %, as of Mar 2025, the value is 38.00%. The value appears strong and on an upward trend. It has increased from 28.00% (Dec 2024) to 38.00%, marking an increase of 10.00%.
• For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 2.00 Cr..
• For Interest, as of Mar 2025, the value is 22.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Dec 2024) to 22.00 Cr., marking an increase of 6.00 Cr..
• For Depreciation, as of Mar 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Dec 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 74.00 Cr.. The value appears strong and on an upward trend. It has increased from 43.00 Cr. (Dec 2024) to 74.00 Cr., marking an increase of 31.00 Cr..
• For Tax %, as of Mar 2025, the value is 28.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Dec 2024) to 28.00%, marking a decrease of 1.00%.
• For Net Profit, as of Mar 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Dec 2024) to 54.00 Cr., marking an increase of 23.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 2.59. The value appears strong and on an upward trend. It has increased from 1.47 (Dec 2024) to 2.59, marking an increase of 1.12.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:39 am

Growth

Last Updated: September 5, 2025, 2:56 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Choice International Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.16. This value is within the healthy range. It has increased from 6.57 (Mar 24) to 8.16, marking an increase of 1.59.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.99. This value is within the healthy range. It has increased from 6.52 (Mar 24) to 7.99, marking an increase of 1.47.
• For Cash EPS (Rs.), as of Mar 25, the value is 8.57. This value is within the healthy range. It has increased from 6.89 (Mar 24) to 8.57, marking an increase of 1.68.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 49.37. It has increased from 29.58 (Mar 24) to 49.37, marking an increase of 19.79.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 51.46. It has increased from 31.67 (Mar 24) to 51.46, marking an increase of 19.79.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 45.60. It has increased from 37.65 (Mar 24) to 45.60, marking an increase of 7.95.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.82. This value is within the healthy range. It has increased from 11.42 (Mar 24) to 14.82, marking an increase of 3.40.
• For PBIT / Share (Rs.), as of Mar 25, the value is 14.39. This value is within the healthy range. It has increased from 11.09 (Mar 24) to 14.39, marking an increase of 3.30.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.08. This value is within the healthy range. It has increased from 9.07 (Mar 24) to 11.08, marking an increase of 2.01.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.15. This value is within the healthy range. It has increased from 6.56 (Mar 24) to 8.15, marking an increase of 1.59.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.15. This value is within the healthy range. It has increased from 6.56 (Mar 24) to 8.15, marking an increase of 1.59.
• For PBDIT Margin (%), as of Mar 25, the value is 32.50. This value is within the healthy range. It has increased from 30.34 (Mar 24) to 32.50, marking an increase of 2.16.
• For PBIT Margin (%), as of Mar 25, the value is 31.56. This value exceeds the healthy maximum of 20. It has increased from 29.46 (Mar 24) to 31.56, marking an increase of 2.10.
• For PBT Margin (%), as of Mar 25, the value is 24.30. This value is within the healthy range. It has increased from 24.08 (Mar 24) to 24.30, marking an increase of 0.22.
• For Net Profit Margin (%), as of Mar 25, the value is 17.87. This value exceeds the healthy maximum of 10. It has increased from 17.43 (Mar 24) to 17.87, marking an increase of 0.44.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 17.87. This value is within the healthy range. It has increased from 17.43 (Mar 24) to 17.87, marking an increase of 0.44.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.50. This value is within the healthy range. It has decreased from 22.19 (Mar 24) to 16.50, marking a decrease of 5.69.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.16. This value is within the healthy range. It has decreased from 24.57 (Mar 24) to 20.16, marking a decrease of 4.41.
• For Return On Assets (%), as of Mar 25, the value is 6.21. This value is within the healthy range. It has decreased from 7.24 (Mar 24) to 6.21, marking a decrease of 1.03.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.29. This value is within the healthy range. It has decreased from 0.38 (Mar 24) to 0.29, marking a decrease of 0.09.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has decreased from 0.77 (Mar 24) to 0.46, marking a decrease of 0.31.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.41. It has decreased from 0.51 (Mar 24) to 0.41, marking a decrease of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 1.58. This value is within the healthy range. It has increased from 1.56 (Mar 24) to 1.58, marking an increase of 0.02.
• For Quick Ratio (X), as of Mar 25, the value is 1.56. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.56.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 87.27. This value exceeds the healthy maximum of 8. It has decreased from 166.83 (Mar 24) to 87.27, marking a decrease of 79.56.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.48. This value is within the healthy range. It has decreased from 5.64 (Mar 24) to 4.48, marking a decrease of 1.16.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.46. This value is within the healthy range. It has decreased from 4.24 (Mar 24) to 3.46, marking a decrease of 0.78.
• For Enterprise Value (Cr.), as of Mar 25, the value is 10,068.01. It has increased from 5,537.18 (Mar 24) to 10,068.01, marking an increase of 4,530.83.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 11.06. This value exceeds the healthy maximum of 3. It has increased from 7.38 (Mar 24) to 11.06, marking an increase of 3.68.
• For EV / EBITDA (X), as of Mar 25, the value is 34.03. This value exceeds the healthy maximum of 15. It has increased from 24.31 (Mar 24) to 34.03, marking an increase of 9.72.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.01. This value exceeds the healthy maximum of 3. It has increased from 7.27 (Mar 24) to 11.01, marking an increase of 3.74.
• For Price / BV (X), as of Mar 25, the value is 10.16. This value exceeds the healthy maximum of 3. It has increased from 9.26 (Mar 24) to 10.16, marking an increase of 0.90.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 11.01. This value exceeds the healthy maximum of 3. It has increased from 7.27 (Mar 24) to 11.01, marking an increase of 3.74.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness